As depicted in Figures 2G,H and 3A, LSD1 inhibitor primarily impacted cell cycle‐associated processes in liver cancer cells and exhibited a role in immune regulation and tumour antigen processing and presentation. This evidence concerns the gene KDM1A and neoplasm.